Integrated Report

Overview

The report describes Pharmaniaga's 2025 transformation following its successful exit from PN17 status and the launch of a new growth chapter under Vision ONE30. The Group reported RM3.9 billion in revenue, expanded its integrated pharmaceutical, manufacturing and logistics capabilities, and continued regional growth across Malaysia and Indonesia. Sustainability highlights include 3,538 employees, zero workplace fatalities, renewable-energy initiatives and improved FTSE4Good performance. The report also presents a Board-led sustainability governance structure and detailed environmental, social and governance disclosures.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services